|Targets||Sphingosine 1 Phosphate Receptor|
|Description||The hydrochloride salt form of CYM 50358, which has been found to be an effective S1P4 antagonist.|
|Purity||≥98% by HPLC|
|Synonyms||CYM 50358 hydrochloride; CYM50358 hydrochloride; CYM-50358 hydrochloride; N-[(4-(Aminomethyl)-2,6-dimethylphenyl]-5-(2,5-dichlorophenyl)-2-furancarboxamide hydrochloride|
JTE 013 has been found to be an antagonist of Sphingosine-1-Phosphate Receptor-2 (S1P2R).
CYM 50260 has been found to be a S1P4 agonist.
Ozanimod, also known as RPC1063, is a selective oral S1P Receptor 1 modulator.
This active molecular is a S1P1/S1P5 agonist with limited activity at S1P3. AMG 369 has no activity at S1P2 and S1P4. AMG-369 is shown to reduce blood lymphocyt...
This active molecular is a selective S1P1 receptor agonist that originated by Bristol-Myers Squibb. BMS-520 shows really good efficacy in animal models of arthr...
CYM 50308 has been found to be an effective and selective S1P4 agonist.
This active moleclar is a Sphingosine 1 Phosphate Receptor antagonists for treatment of multiple sclerosis (MS) and other autoimmune diseases originated by Aren...
CS-0777 is a selective sphingosine 1-phosphate receptor modulator agonist. It is in clinical trials for the treatment of multiple sclerosis, but no recent devel...